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ABSTRACT 
Objective: The thought of providing the best quality of medicines at cheaper costs made the governments to think of generic drug substitutions in 
order to minimize the economic burden. This study was designed to investigate the attitude of physicians and pharmacists towards generic 
medicines and thus to reduce the gap between them.  
Methods: This is a simple, prospective, cross-sectional, comparative study conducted for a period of 3 mo. 100 Subjects (50 pharmacists and 50 
physicians) were included in this study. Subjects who ever graduated with the pharmacy degree and working as pharmacists, as well as clinical 
practitioners, were included in this study. Data collected using a validated questionnaire. 
Results: 60% of physicians and 80% of pharmacists were confident enough in dispensing generic products. 56% of physicians agree that 
pharmacists play a vital role in providing assistance on the use of generic medicines. 70% of physicians and 90% of pharmacists agreed that the 
generic medicines are of less expensive. 
Conclusion: Our Study concludes that pharmacist’s shows a higher positive response towards the usage of generic products than physicians. Generic 
drugs typically cost 30% to 60% less than their brand products. In addition, patients taking generic drugs seem to be more willing to continue therapy. 
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The high cost of medicines in India has made the treatment of many 
diseases unaffordable to the poor and even has become a strain on 
the budgets of middle-class citizens. For the patients’ health 
importance, best quality of medicines should be provided, and this 
has become a major economic challenge especially in the developing 
countries [1]. The thought of providing the best quality of medicines 
at cheaper costs made the governments to think of generic drug 
substitutions in order to minimize the economic burden [2]. A 
generic drug is referred as ‘a pharmaceutical product that can be 
indistinguishable with the innovator product in terms of 
composition, quality, safety, and efficacy and also therapeutically 
equivalent to the original drug product [3]. Generic drugs are less 
expensive comparable, hence rescue costs on medicines [4]. This 
lesser cost are the reason for that innovator product cannot be 
protected by patents for longer periods, and after the expiry of these 
patents, the generic drug manufacturers can formulate the product 
by ignoring the steps such as drug discovery, preclinical and clinical 
trials for which lots of money should be afforded [5]. Generic 
products are usually 20-80% cheaper than branded drugs [6]. Some 
doctors are reported to receive substantial incentives from 
pharmaceutical companies to prescribe the branded products. When 
the prescriptions are for expensive branded generics, or for the even 
more expensive brands, then patients suffer greater financial 
exploitation [7]. This ‘symbiotic’ relationship between the 
pharmacist and medical professionals has greater implications for 
the developing countries such as India, with high private 
participation in the healthcare sector, low public health expenditure 
by government combined with rampant unethical practices of 
pharma companies and doctors resulting in huge out of pocket 
expenditure [8]. The issues considered in this section are real 
problems, and one way of addressing them would be to move 
prescriptions from expensive brands to low-cost generic [7]. Generic 
drugs can be considered replaceable without any concerns about 
safety and efficacy, as they are therapeutically equivalent to their 
original drug counterparts. Hence, generic drug usage is an 
important strategy to reduce pharmaceutical expenditures of public 
[9]. Lower cost is the major factor leading all the health care 
professionals towards generic medicine utilization. The role of the 
pharmacist in generic medication selection is versatile [10]. 
Pharmacist role includes the selection of generic substitute that is 
bioequivalent to the innovator product, educating both patients and 
health care professionals about their quality as well as safety and also 
promoting the compliance with therapy among patients [11]. Many 
factors such as lack of knowledge and insufficient awareness regarding 
efficacies and safeties among practitioners and pharmacists may 
influence selecting, prescribing and dispensing of generic medicines 
[12]. Moreover, misinformation and liaison of health care providers 
with the pharmaceutical companies may lead to the highest 
pharmaceutical expenditures for the patients [13]. Recently, many 
studies were conducted to create awareness and to provide 
knowledge on the benefits of generic medicine use. Most of the health 
care providers are also reinforcing the generic medicine utilization. 
Hence, this study was designed to investigate the attitude of physicians 
and pharmacists towards generic medicines and thus to reduce the 
gap between them.  
MATERIALS AND METHODS 
Study design and data collection 
This is a simple, prospective, cross-sectional, comparative study 
conducted for a period of 3 mo (December 2017-January 2018). The 
Institutional Ethics Committee of RVS Institute of Medical Sciences 
approved this study (Approval No: IEC/RVSIMS/2017/09). 100 Subjects 
(50 pharmacists and 50 physicians) were included in this study. Subjects 
who ever graduated with the pharmacy degree and working as a 
community, hospital or clinical pharmacist, as well as clinical 
practitioners, were included in this study. Data’s were collected using a 
validated self-administered questionnaire consisted of structured and 
open questions which were developed referring to previous literature. 
The validated questionnaire was issued to the subjects and sufficient 
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time was given to them to answer the questionnaire. Verbal consent was 
obtained from each subject during data collection. The confidentiality of 
the data obtained was assured, and the personal details of the subject 
were omitted from the questionnaire.  
Statistical analysis 
The collected data were entered in Microsoft Excel 2010 and analyzed 
using Graph Pad Prism 7.0 software. Student t-test was used to 
determine the presence or absence of statistically significant difference 
in the attitudes of the study population. Data were analyzed using 
descriptive statistics for the tables of frequency, and its associate 
percentage was calculated. Chi-square test was used wherever 
necessary. Wherever computed, a P value of less than 0.05 was 
considered significant; since the confidence interval was maintained at 
95%.  
RESULTS 
A total of 100 subjects were enrolled and randomized equally into 
two groups (50 each). The baseline data distribution of the subjects 
included in the study is shown in fig. 1, 2 and 3. Gender wise 
distribution is shown in fig. 1, and the difference is estimated by 
using the chi-square test. Department wise data distribution among 
physicians and pharmacists are shown in fig. 2 and 3. 
 
 
Fig. 1: Gender wise distribution among professionals, P value, 
was found to be 0.8407 which describes the statistically 
significant difference is not seen in the gender among two 
groups of professionals 
 
Fig. 2: Physician’s department wise distribution 
 
 
Fig. 3: Pharmacist’s department wise distribution 
 
Evaluation of a questionnaire 
The response to the questionnaire was categorized into three: agree, 
neutral and disagree. A statistically significant difference in the 
response rate was found between the professionals. A positive 
response was seen more in pharmacists group whereas negative 
response was seen more in physicians group. The response rate 
obtained by each question and P value is shown in table 1. 
 
Table 1: Evaluation of attitude of professionals towards generic products usage 
Questions Agree N (%) Neutral N (%) Disagree N (%) 
Physician Pharmacist Physician Pharmacist Physician Pharmacist 
Q1 28(56) 40(80) 9(18) 4(8) 13(26) 6(12) 
Q2 24(48) 38(76) 16(32) 7(14) 10(20) 5(10) 
Q3 30(60) 30(60) 10(20) 8(16) 10(20) 12(24) 
Q4 28(56) 32(64) 12(24) 9(18) 10(20) 9(18) 
Q5 35(70) 45(90) 7(14) 3(6) 8(16) 2(4) 
Q6 30(60) 40(80) 9(18) 6(12) 11(22) 4(8) 
Q7 27(54) 46(92) 13(26) 1(2) 10(20) 3(6) 
Q8 28(56) 40(80) 12(24) 4(8) 10(20) 6(12) 
Q9 26(52) 22(44) 13(26) 17(34) 11(22) 11(22) 
Q10 25(50) 32(64) 7(14) 10(20) 18(36) 8(16) 
Q11 23(46) 37(74) 15(30) 7(14) 12(24) 6(12) 
P Value 0.0013* 0.0161* 0.0016* 
 
Questionnaire 
Q1-All generic products of a particular medicine that are rated as generic 
equivalents are therapeutically equivalent to their brand products. 
Q2-All generic products of a particular medicine are bioequivalent to 
their brand products. 
Q3-Generic medicines have good quality and efficacy as brand products. 
Q4-Generic medicines produce lesser side-effects than brand products. 
Q5-Generic medicines are less expensive than brand products. 
Brand products are required to meet higher safety standards than 
generic medicines. 
Q6-Confident enough in dispensing generic drugs rather than brand 
products. 
Q7-It is easier to recall a medicine's therapeutic class using generic 
names rather than brand products. 
Q8-I believe that pharmacists are one of the most important health 
care professionals to give advice on generic medicines. 
Q9-Generic products will not differ from FDA standards. 
Q10-All brand products can be substituted by generic products. 
Q11-Pharmaceutical companies are benefitted more by 
manufacturing brand products than generic products. 
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DISCUSSION  
Generic medicines are copies of brand medicines in terms of dosage, 
side effects, safety, risks, route of administration, strength as well as 
efficacy. Generic drug differs from the brand medicine only in non-
essential characteristics such as color, taste, and packaging [14]. 
Generic medicines serve as the cost-effective treatment. The low 
cost of generic medicines is due to the reason that they will be 
manufactured only after the expiry of the patent of brand medicine. 
Although generic drugs may not differ from branded medicines, 
brand medicines are of high cost comparatively [15]. Among the 
subjects participated in the present study, the majority of them are 
male in both the groups which is shown in fig. 1. In this study, 56% 
of the physicians and 80% of the pharmacists have agreed that 
generic medicine can be therapeutically equivalent to a brand 
medicine. Thus the pharmacists believe more in generic medicines 
compared to physicians, and it complies with the results of Josef 
Maly et al. study [16]. In terms of bioequivalence, 76% of 
pharmacists have agreed that the generic medicines are 
bioequivalent to brand medicines whereas only 48% physicians 
agreed and these results comply with the study results of Abadi et al. 
study [17]. In addition, 32% of the physicians have shown a neutral 
response to the above statement which is due to lack of awareness 
about generic medicines to the physicians. 60% of both pharmacists 
and physicians believe that the generics are equivalent to the brand 
in terms of quality and efficacy which complies with the study report 
conducted by shadhi S et al. [18]. In the present study, 56% of 
physicians and 64% of pharmacists agreed that the generics produce 
lesser side effects compared to brand medicines whereas 24% and 
18% of physicians and pharmacists were shown neutral response as 
well as 20% and 18% of physicians and pharmacists disagreed 
which is similar to the result of Catic et al. study [19]. 70% of 
physicians and 90% of pharmacists agreed that the generic 
medicines are of less expensive whereas 14% and 16% of physicians 
were neutral and disagreed. Higher positive response rate was 
found in pharmacist, which complies with Hassali et al. study result 
since pharmacists are well aware of generic medicines than 
physicians [20]. 60% of physicians and 80% of pharmacists were 
confident enough in dispensing generic products. Only 12% of 
pharmacists were neutral, and 8% are not confident. Majority of the 
pharmacists (about 92%) have agreed that it is easier to memorize 
the drug with its generic name whereas only 54% of physicians have 
agreed on which is same as stated by Paveliu et al. study result [21]. 
56% of physicians agree that pharmacists play a vital role in 
providing assistance on the use of generic medicines but 24% of 
them were neutral, and 20% of them disagreed, but a study 
conducted by Akhtar et al. stated that pharmacists were competent 
and knowledgeable enough in guiding the use of generic medicines 
[22]. 52% and 44% of physicians and pharmacists believe that 
generic medicines differ from FDA standards 
CONCLUSION 
in case of identity, 
strength, quality, and purity of drug products. Majority of the 
physicians (50%) and pharmacists (64%) agreed that generic drugs 
serve as a substitute for brand drugs and it complies with the results 
of O’Leary et al. [23]. Most of the pharmacists (74%) and few 
physicians (46%) support that pharmaceutical companies are 
benefitted more by manufacturing brand products.  
Our Study concludes that pharmacist’s shows a higher positive 
response towards the usage of generic products than physicians. The 
limitation of the study is a smaller sample size. Generic drugs 
typically cost 30% to 60% less than their brand products. In 
addition, patients taking generic drugs seem to be more willing to 
continue therapy than those taking brand-name medications since 
the cost of generic products is less and also produce lesser side 
effects. Therefore, awareness of generic medicine usage should be 
generated among physicians as well as other health care 
professionals to make the medicine more affordable to people on 
low income. 
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